| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $5.86B | $7.29B | $4.63B | $5.51B | $5.13B |
| R&D | – | – | – | – | – |
| SG&A | $350.00M | $372.00M | $351.00M | $483.00M | $376.00M |
| Operating Income | $3.09B | $2.44B | $3.65B | $5.57B | $2.86B |
| Interest Expense | $323.00M | $402.00M | $351.00M | $332.00M | $419.00M |
| Tax Expense | $1.10B | $417.00M | -$324.00M | $1.65B | $578.00M |
| Net Income | $1.43B | $1.12B | $3.21B | $4.08B | $1.31B |
| EPS (basic) | 3.9900 | 2.2800 | 9.2600 | 11.0500 | 2.6000 |
| EPS (diluted) | 3.9900 | 2.2700 | 9.2500 | 11.0200 | 2.5900 |
| Shares (diluted) | $359.00M | $353.00M | $309.00M | $333.00M | $375.00M |